Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections

被引:1
|
作者
Zeng, Juan [1 ]
Leng, Bing [2 ]
Guan, Xiaoyan [1 ]
Jiang, Shuangyan [1 ]
Xie, Maoyu [3 ]
Zhu, Wenying [1 ]
Tang, Yue [1 ]
Zhang, Lin [1 ]
Sha, Jing [1 ]
Wang, Tengfei [1 ]
Ding, Min [1 ]
Guo, Nan [2 ]
Jiang, Jinjiao [1 ]
机构
[1] Shandong First Med Univ, Dept Crit Care Med, Shandong Prov Hosp Affiliated, Jinan, Shandong, Peoples R China
[2] Shandong First Med Univ, Dept Pharm, Shandong Prov Hosp Affiliated, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Dept Emergency, Shandong Prov Hosp Affiliated, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
polymyxin B; pharmacokinetics; elderly; critical care; total body weight; renal function;
D O I
10.3389/fphar.2024.1347130
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Elderly patients are more prone to develop acute kidney injury during infections and polymyxin B (PMB)-associated nephrotoxicity than young patients. The differential response to PMB between the elderly and young critically ill patients is unknown. We aimed to assess PMB exposure in elderly patients compared with young critically ill patients, and to determine the covariates of PMB pharmacokinetics in critically ill patients. Methods: Seventeen elderly patients (age >= 65 years) and six young critically ill patients (age < 65 years) were enrolled. Six to eight blood samples were collected during the 12 h intervals after at least six doses of intravenous PMB in each patient. PMB plasma concentrations were quantified by high-performance liquid chromatography-tandem mass spectrometry. The primary outcome was PMB exposure as assessed by the area under the concentration-time curve over 24 h at steady state (AUC(ss, 0-24 h)). Results and Discussion: The elderly group had lower total body weight (TBW) and higher Charlson comorbidity scores than young group. Neither AUC(ss, 0-24 h) nor normalized AUC(ss, 0-24 h) (adjusting AUC for the daily dose in mg/kg of TBW) was significantly different between the elderly group and young group. The half-life time was longer in the elderly patients than in young patients (11.21 vs 6.56 h respectively, p = 0.003). Age and TBW were the covariates of half-life time (r = 0.415, p = 0.049 and r = -0.489, p = 0.018, respectively). TBW was the covariate of clearance (r = 0.527, p = 0.010) and AUC(ss, 0-24 h) (r = -0.414, p = 0.049). Patients with AUC(ss, 0-24 h) >= 100 mg<middle dot>h/L had higher baseline serum creatinine levels and lower TBW than patients with AUC(ss, 0-24 h) < 50 mg<middle dot>h/L or patients with AUC(ss, 0-24 h) 50-100 mg<middle dot>h/L. The PMB exposures were comparable in elderly and young critically ill patients. High baseline serum creatinine levels and low TBW was associated with PMB overdose.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Predictors of polymyxin B treatment failure in Gram-negative healthcare-associated infections among critically ill patients
    Ismail, Bahiah
    Shafei, Mohd Nazri
    Harun, Azian
    Ali, Saedah
    Omar, Mahamarowi
    Deris, Zakuan Zainy
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 763 - 769
  • [22] Outcome of Using Intraventricular Plus Intravenous Polymyxin B in Post-neurosurgical Patients With Multi/Extensively Drug-Resistant Gram-Negative Bacteria-Induced Intracranial Infection
    Li, Hangyang
    Yu, Wenqiao
    Wang, Guobin
    Cai, Hongliu
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients
    Balandin, Barbara
    Pintado, Vicente
    Perez-Pedrero, Maria Jose
    Martinez-Sagasti, Fernando
    Sancho-Gonzalez, Milagros
    Soriano-Cuesta, Cruz
    Gesso, Cristina Martin-Dal
    Chicot, Marta
    de Luna, Rafael Ruiz
    Asensio-Martin, Maria Jose
    Catalan, Mercedes
    Diaz-Diaz, Juan Jose
    Carbonell, Nieves
    Iranzo, Reyes
    Royuela, Ana
    Ballesteros, Daniel
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (05)
  • [24] Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients
    Balandin, Barbara
    Ballesteros, Daniel
    Pintado, Vicente
    Soriano-Cuesta, Cruz
    Cid-Tovar, Irene
    Sancho-Gonzalez, Milagros
    Jose Perez-Pedrero, Maria
    Chicot, Marta
    Jose Asensio-Martin, Maria
    Alberto Silva, Jose
    Ruiz de Luna, Rafael
    Martin-Dal Gesso, Cristina
    Anibal Rodriguez-Serrano, Diego
    Martinez-Sagasti, Fernando
    Royuela, Ana
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (03)
  • [25] Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
    Carolin Prinz
    Frank Streit
    Christian Schumann
    Anna Dudakova
    Christian Lanckohr
    Julie Schanz
    Matthias Bohn
    Uwe Groß
    Konrad Meissner
    Onnen Moerer
    Lars-Olav Harnisch
    Clinical Drug Investigation, 2023, 43 (4) : 307 - 314
  • [26] Feasibility of Continuous Infusion of Cefiderocol in Conjunction with the Establishment of Therapeutic Drug Monitoring in Patients with Extensively Drug-Resistant Gram-Negative Bacteria
    Prinz, Carolin
    Streit, Frank
    Schumann, Christian
    Dudakova, Anna
    Lanckohr, Christian
    Schanz, Julie
    Bohn, Matthias
    Gross, Uwe
    Meissner, Konrad
    Moerer, Onnen
    Harnisch, Lars-Olav
    CLINICAL DRUG INVESTIGATION, 2023, 43 (04) : 307 - 314
  • [27] Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients
    Cohen, Jonathan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 490 - 491
  • [28] Negative Pressure Wound Treatment of Infections Caused By Extensively Drug-Resistant Gram-Negative Bacteria After Liver Transplantation: Two Case Reports
    Dondossola, D.
    Cavenago, M.
    Piconi, S.
    Antonelli, B.
    Melada, E.
    Lonati, C.
    Gatti, S.
    Rossi, G.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (07) : 2145 - 2149
  • [29] Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
    Zhou, Li
    Feng, Shanglong
    Sun, Guangyu
    Tang, Baolin
    Zhu, Xiaoyu
    Song, Kaidi
    Zhang, Xuhan
    Lu, Huaiwei
    Liu, Huilan
    Sun, Zimin
    Zheng, Changcheng
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 481 - 491
  • [30] Predictors of mortality in patients with extensively drug-resistant gram-negative pneumonia receiving colistin therapy
    Wi, Y. M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S110 - S111